Frontier Pharma: Pain – Identifying and Commercializing First-in-Class Innovation
(EMAILWIRE.COM, May 09, 2015 ) GBI ResearchÂ’s analyses identified 122 first-in-class programs in active development, constituting 13.6% of the pipeline ...
Read more